Smoking Cessation Clinical Trial
Official title:
Computerized Anger-Reduction Treatment for Smoking Cessation
Verified date | January 2021 |
Source | Florida State University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Problematic anger is a strong predictor of failed attempts at smoking cessation. The investigators proposed study seeks to evaluate whether a novel 8-session computerized anger-reduction treatment improves quit rates among smokers. Smokers with elevated trait anger will be administered transdermal nicotine patch therapy and either anger-reduction treatment or a control intervention. They will be assessed throughout treatment and up until three months after a scheduled mid- treatment quit date. The investigators propose to test whether, compared to the control condition, the anger-reduction treatment will lead to: 1) greater reductions in anger and 2) greater abstinence rates at post-cessation and at follow-up assessments. The investigators will also test whether changes in anger-related symptoms account for group differences in abstinence rates.
Status | Completed |
Enrollment | 100 |
Est. completion date | July 30, 2019 |
Est. primary completion date | July 30, 2019 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 65 Years |
Eligibility | Inclusion Criteria: - Elevated levels of trait anger (scoring 22 or higher on the STAXI-trait) - Currently smoking an average of 8 cigarettes per day - Must be a regular (daily) smoker for at least 1 year - Willing to make a serious attempt to quit smoking - Must report motivation to quit in the next month (30 days) of at least 5 on a 10 point scale (0 = no motivation and 10 = extreme motivation) - Have not decreased the number of cigarettes by more than half in the past six months - Must be an English speaker Exclusion Criteria: - Current substance dependence (excluding nicotine dependence) - Current use of other tobacco products - Currently receiving cognitive therapy or therapy for problematic anger - Evidence of serious suicidal intent requiring hospitalization or immediate treatment - Limited mental competency and the inability to give informed, written consent - Evidence of psychotic-spectrum disorders - Changes in medication over the last month |
Country | Name | City | State |
---|---|---|---|
United States | Florida State University, Department of Psychology | Tallahassee | Florida |
Lead Sponsor | Collaborator |
---|---|
Florida State University |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | State-Trait Anger Expression Inventory-2 (STAXI-2; Spielberger, 1999) state and trait subscales | up to 14-weeks following treatment initiation. | ||
Primary | Self-reported smoking frequency | up to 14-weeks following treatment initiation. | ||
Primary | Carbon monoxide levels | up to 14-weeks following treatment initiation. | ||
Secondary | Minnesota Nicotine Withdrawal Scale (Hughes & Hatsukami, 1986) | up to 14-weeks following treatment initiation. | ||
Secondary | Beck Depression Inventory-II (Beck, Steer, & Brown, 1996) | Baseline and regularly for 14-weeks following treatment initiation. | ||
Secondary | Clinical Anger Scale (CAS; Snell, Gum, Shuck, Mosley, & Hite, 1995) | up to 14-weeks following treatment initiation. | ||
Secondary | WSAP-Hostility Scale (Dillon, Cougle, & Fincham, 2015) | up to 14-weeks following treatment initiation. | ||
Secondary | Hostile Automatic Thoughts Scale (Snyder, Crowson, Houston, Kurylo, & Piorier, 1997) | up to 14-weeks following treatment initiation | ||
Secondary | Questionnaire of Smoking Urges (Tiffany & Drobes, 1991) | up to 14-weeks following treatment initiation. |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03999411 -
Smartphone Intervention for Smoking Cessation and Improving Adherence to Treatment Among HIV Patients
|
Phase 4 | |
Completed |
NCT04043728 -
Addressing Psychological Risk Factors Underlying Smoking Persistence in COPD Patients: The Fresh Start Study
|
N/A | |
Completed |
NCT04617444 -
The ESTxENDS Trial- Substudy on Effects of Using Electronic Nicotine Delivery Systems (ENDS) on Olfactory Function
|
N/A | |
Completed |
NCT02796391 -
Facilitating Smoking Cessation With Reduced Nicotine Cigarettes
|
Phase 2 | |
Completed |
NCT03397511 -
Incorporating Financial Incentives to Increase Smoking Cessation Among Asian Americans Residing in New York City
|
N/A | |
Not yet recruiting |
NCT05188287 -
A Culturally Tailored Smartphone Application for African American Smokers
|
N/A | |
Recruiting |
NCT05264428 -
The Effect of Honey on Lessening the Withdrawal Symptoms
|
N/A | |
Recruiting |
NCT05846841 -
Personalized Tobacco Treatment in Primary Care (MOTIVATE)
|
N/A | |
Completed |
NCT04133064 -
Assessment of the Pivot Breath Sensor: Single-Arm Cohort Study
|
N/A | |
Completed |
NCT03187730 -
Integrating Financial Management Counseling and Smoking Cessation Counseling to Reduce Health and Economic Disparities in Low-Income Immigrants
|
Phase 4 | |
Completed |
NCT03474783 -
To Explore the Factors Affecting the Effectiveness of Smoking Cessation
|
N/A | |
Completed |
NCT04635358 -
Feasibility Study of Smoking Cessation for the Staff of a Hospital Center
|
N/A | |
Terminated |
NCT03670264 -
BE Smokefree: Behavioral Economics Incentives to Engage Adolescents in Smoking Cessation
|
N/A | |
Not yet recruiting |
NCT06307496 -
VIDeOS for Smoking Cessation
|
N/A | |
Completed |
NCT03206619 -
A Health Recommeder System to Tailor Message Preferences in a Smoking Cessation Programme
|
||
Completed |
NCT02997657 -
Positive Psychotherapy for Smoking Cessation Enhanced With Text Messaging: A Randomized Controlled Trial
|
N/A | |
Completed |
NCT02905656 -
Strategies to Promote Cessation in Smokers Who Are Not Ready To Quit
|
N/A | |
Completed |
NCT02239770 -
Pharmacokinetics of Nicotine Film in Smokers
|
N/A | |
Completed |
NCT02562521 -
A Smoking Cessation Intervention for Yale Dining Employees
|
Phase 4 | |
Recruiting |
NCT02422914 -
Benefits of Tobacco Free Cigarette
|
N/A |